Cancer Screening Tool Reduces Costs And Invasiveness
Inaccurate and unnecessary cancer screenings cost $88.7 billion annually.
As mounting pressure is put on the healthcare system to reduce costs while improving outcomes, there is a growing need for increased accuracy and closer vetting of testing done to screen for cancer and other diseases. Inaccurate and unnecessary cancer screenings in the U.S. cost an estimated $88.7 billion a year as physicians perform more screenings than in any other country with advanced healthcare. As cancer rates are anticipated to grow by 57 percent worldwide over the next twenty years, the economic impact of these continued screenings must be addressed.